Relationship between epicardial adipose tissue thickness and sedentary time, physical activity level, and physical performance in patients with hypertension

Introduction

The development of cardiovascular disease is associated with obesity and visceral adipose tissue accumulation as well as increased cardiac adipose tissue [1,2,3]. Epicardial adipose tissue (EAT), a cardiac visceral fat depot, has been shown to contribute to the development and progression of atrial fibrillation and heart failure with preserved ejection fraction [4]. In addition, it has been reported that EAT may be a marker auxiliary to classical risk factors for the presence and severity of coronary artery disease [5]. EAT thickness is also associated with metabolic syndrome and hypertension, high levels of low-density lipoprotein cholesterol, and insulin resistance [6,7,8,9].

The EAT is located between the myocardium and the pericardium and is therefore in direct contact with the main coronary arteries and their branches [10]. Under normal conditions, EAT is thought to be able to metabolize large amounts of fatty acids. Thus, it is suggested to play a cardioprotective role by preventing the formation of atherosclerotic plaques [1, 11]. Increased EAT has been shown to affect the cardiovascular system by increasing the release of inflammatory mediators that cause atherosclerosis and vascular endothelial dysfunction [2, 12, 13]. Studies have shown that the EAT of individuals diagnosed with hypertension is thicker than that of normotensive individuals and EAT thickness is positively correlated with blood pressure levels [9, 14].

Many studies have shown that regular physical activity, which is considered an effective non-pharmacological treatment method in the management of hypertension, is associated with lower blood pressure and lower incidence of hypertension [15, 16]. Our search of the literature revealed no study evaluating the relationship between physical activity and physical performance levels in hypertensive individuals and EAT thickness. The aim of the present study was to examine the relationship between EAT thickness and sedentary time, physical activity level, and physical performance in hypertensive patients.

Methods

The study included 40 patients with a diagnosis of hypertension who presented to the cardiology outpatient clinics of Karaman Training and Research Hospital between December 6, 2021 and February 28,2022. Karamanoğlu Mehmetbey University Faculty of Medicine (Non-Interventional) Approval was obtained from the Ethics Committee (Ethics Committee Decision No 07- 2021/05 and ClinicalTrials.gov Identifier: NCT05890989). Before the study, the purpose and content of the study were explained to participants. Written informed consent was obtained from the participants stating that they participated in the study voluntarily.

Participants

Volunteers who had been diagnosed with hypertension for at least 6 months, could speak Turkish, were literate, and aged 18–65 years were included in the study. Individuals with severe valvular disease, heart failure, cardiomyopathy, diabetes mellitus, chronic kidney disease, thyroid diseases, hyperlipidemia, active infectious or inflammatory diseases, or serious psychiatric diseases such as panic disorder or major depression, smoking were excluded. As a result of the power analysis, the sample size required to find a significant relationship of 50.9%, which was obtained as a result of the pilot study, between EAT thickness and physical activity level with 5% error level and 95% power was calculated as 37 individuals.

Evaluation

The physical and demographic characteristics of the participants (age, sex, height, body weight, body mass index (BMI), educational status, employment status, duration of hypertension disease, medications, and comorbidity) were recorded. Waist/hip circumference measurements were recorded by the same investigator using a tape measure. Office blood pressure (BP) was measured after 5 min of rest in a quiet environment using a oscillometric device with the upper arm cuff with the patient in a sitting position. Patients were advised to refrain from smoking, physical exercise, and consumption of coffee and tea 30 min before BP measurements.

All patients underwent transthoracic echocardiography conducted by a single cardiologist using a Philips HD11XE (Philips Medical Systems) device in the left lateral decubitus position by the standard technique. Epicardial fat thickness was measured in the parasternal long axis imaging window, using the aortic annulus as an anatomical indicator for vertical measurement, and the widest part of the region from the right ventricular free wall to the pericardium at the end of the systole [17].

The physical performance of the participants was evaluated with the 30-s sit-and-stand test. While seated in a chair with a seat height of 43.2 cm and a supported back, the patient was asked to stand up and sit down as quickly as possible while crossing his/her hands over his/her chest. The 30-s duration of the test was monitored with a stopwatch and the number of times the participant stood up and sat down was noted. Two trials were performed before the test [18].

Physical activity level was evaluated with the Turkish version of the International Physical Activity Questionnaire-7 (IPAQ-7), whose reliability and validity were confirmed by Saglam et al. [19]. The IPAQ-7 is a seven-item questionnaire that assesses severe physical activity (duration: min and frequency: day), moderate physical activity (duration: min and frequency: day), and walking time of at least 10 min (frequency: day) over the previous seven days. The metabolic equivalent of task (MET) corresponding to the basal metabolic rate is converted from severe and moderate activity and walking periods, and the overall physical activity score (MET- min/week) is determined.

Statistical analysis

The statistical analyses were performed with IBM SPSS Statistics V23. The data were analyzed using normality tests (Shapiro–Wilk test for n < 50 and Kolmogorov–Smirnov test for n ≥ 50) and graphs such as histograms and qq plots. The relationships between variables were analyzed by Pearson’s correlation coefficient for normally distributed variables and Spearman’s correlation coefficient and multiple linear regression analysis for non-normally distributed variables. Comparisons between two independent groups were analyzed with the significance test of the difference between two means (independent t-test) when the parametric test assumptions were met, and with the Mann–Whitney U test when they were not. Comparisons between more than two independent groups were analyzed by one-way ANOVA when parametric test assumptions were met and by Kruskal–Wallis test when not met. Continuous variables in the physical and demographic data are expressed as mean (X) ± standard deviation (SD) and median (minimum- maximum) depending on the distribution. Categorical variables, such as sex, are expressed as numbers (%).

Results

The physical and demographic findings of the patients included in the study are presented in Table 1. The median hypertension duration was 42 (min-max = 12–240) months.

Table 1 Physical and demographic findings and evaluation results of the participants.
Full size table

The IPAQ-7 and sit-and-stand test scores, EAT thickness, and hours spent sitting during the day of the patients included in the study are presented in Table 2.

Table 2 Participants’ evaluation results.
Full size table

There was a moderate negative correlation (rho: −0.568 p < 0.001) between EAT thickness and IPAQ-7 score and a high negative correlation (rho: −0.794 p < 0.001) between EAT thickness and sit-and-stand test score. There was no statistically significant relationship between EAT thickness and daily sitting time, BMI, or hip circumference. There was a moderate positive correlation between EAT thickness and age (rho: 0.504 p: 0.001) and a low positive correlation between EAT thickness and waist circumference (rho: 0.322 p < 0.05) (Table 3).

Table 3 The relationship between EAT and IPAQ-7, sit-and-stand test score, daily sitting time, age, BMI, and anthropometric measurements.
Full size table

As a result of the multiple regression analysis performed with the model consisting of the variables determined to have statistically significant relationships in the analyses and the EAT thickness variable, the IPAQ-7 score, sit-and-stand test score, age, and waist circumference were determined as independent-explanatory variables. However, the presence of high correlations between the independent variables (for example, there is a 75.9% correlation between IPAQ-7 score and sit-and-stand score) affected the significance of all variables in the model. Therefore, only significant variables were left in the model by using stepwise variable selection. The independent variables that provided model fit are shown in Table 4. The regression model obtained as a result of the analysis was universally significant (F = 28.478, p < 0.001). Sit-and-stand score and waist circumference together can explain 58.5% of the change in EAT thickness. As the sit-and-stand score increases by 1 unit, EAT thickness decreases by 0.439 mm on average. As waist circumference increases by 1 unit, EAT thickness increases by 0.036 mm. According to the beta coefficients, sit-and-stand score was more influential on EAT than waist circumference was.

Table 4 Regression analysis results for the effect of sit-and-stand score and waist circumference on EAT thickness.
Full size table

Discussion

To the best of our knowledge, this is the first study to evaluate the relationship between EAT thickness and sedentary time, physical activity level, and physical performance in patients with hypertension. Our study showed that EAT thickness was negatively associated with physical activity and physical performance in these patients. No relationship was found between EAT thickness and daily sitting time.

The negative correlation in our study between physical activity level and EAT thickness in hypertensive individuals may be explained by the fact that physical activity is an effective intervention in reducing adiposity [20]. The inverse relationship between physical activity and EAT is consistent with the literature reporting a decrease in visceral adipose tissue in response to physical activity [21, 22]. It is similar to some studies in the literature showing reductions in ectopic liver fat and visceral adiposity with even very low levels of physical activity [20, 23]. In the World Health Organization’s physical activity and sedentary time 2020 guideline, the recommendation for physical activity in all age groups to reduce adiposity was expressed as critically important [24]. There are no studies in the literature investigating the relationship between physical activity level and EAT thickness. However, different exercise interventions ranging from moderate to high intensity in various patient populations with increased CVD risk were found to be effective in reducing EAT and improving metabolic parameters [1, 13, 25]. Another important finding of our study, namely the negative correlation between the physical performance levels of hypertensive individuals and EAT thickness, may have been due to the complex interaction of factors such as increased levels of inflammatory mediators and insulin resistance as a result of increased EAT thickness and decreased muscle function [25]. In addition, increased EAT thickness has been associated with lower exercise capacity [26].

There are no studies in the literature investigating the relationship between daily sitting time and EAT thickness. In our study, no relationship was found between EAT thickness and sitting time, in contrast to the positive relationship found between sitting time and pericardial fat by Larsen et al. [27]. This difference may be because our study was conducted in a smaller sample with a different ethnic origin. In addition, in a study analyzing the relationship between sedentary time and visceral adiposity, no relationship was found between these two parameters [22].

Another finding of our study was a positive correlation between EAT thickness and age and waist circumference. No significant correlation was found between EAT thickness and BMI or hip circumference. In the study conducted by Gorter et al. in heart failure patients, higher BMI was directly associated with increased EAT [26]. In the study by Pierdomenico et al. there was no significant relationship between EAT and age, BMI, or waist circumference [28]. Differences between the associations may have been due to population differences in the studies. In some studies, reduction in BMI with diet-based interventions was significantly associated with decreased EAT [29].

Finally, there are still many questions to be answered about sedentary behavior, physical activity, physical performance, and EAT. An important limitation of the available data is that physical activity and sedentary time are measured by self-report through scales and not further validated. Future research is recommended to determine whether these relationships are also observed when using objective measures of activity and sitting. The fact that this is the first study to examine the relationship between sedentary behavior, physical activity, physical performance, and EAT in hypertensive individuals limits interpretation of the findings, and further studies with a larger sample group are needed to confirm these relationships.

Conclusions

In the present study EAT thickness was negatively associated with physical activity and physical performance in hypertensive patients, but not with daily sitting time. This result shows the importance of the effect of being physically active on blood pressure and EAT. Based on these results, lifestyle change can be emphasized, and rehabilitation can be supported in chronic disease management and prevention.

Summary

What is known about topic:

  • Epicardial adipose tissue (EAT), which is considered a risk factor for coronary artery disease, is also associated with high blood pressure.

  • Recent clinical and experimental studies contain evidence that physical activity (PA) is effective in reducing EAT.

What this study adds:

  • EAT decreases as PA level and physical performance increase in individuals with hypertension. This outcome highlights the significance of the connection between PA and EAT.

  • Therefore, it may be beneficial for healthcare professionals to encourage hypertensive patients to adopt a more active lifestyle and to provide support for rehabilitation as part of a comprehensive approach to managing and preventing chronic diseases.

Related Articles

Energy metabolism in health and diseases

Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Macrophages are immune cells belonging to the mononuclear phagocyte system. They play crucial roles in immune defense, surveillance, and homeostasis. This review systematically discusses the types of hematopoietic progenitors that give rise to macrophages, including primitive hematopoietic progenitors, erythro-myeloid progenitors, and hematopoietic stem cells. These progenitors have distinct genetic backgrounds and developmental processes. Accordingly, macrophages exhibit complex and diverse functions in the body, including phagocytosis and clearance of cellular debris, antigen presentation, and immune response, regulation of inflammation and cytokine production, tissue remodeling and repair, and multi-level regulatory signaling pathways/crosstalk involved in homeostasis and physiology. Besides, tumor-associated macrophages are a key component of the TME, exhibiting both anti-tumor and pro-tumor properties. Furthermore, the functional status of macrophages is closely linked to the development of various diseases, including cancer, autoimmune disorders, cardiovascular disease, neurodegenerative diseases, metabolic conditions, and trauma. Targeting macrophages has emerged as a promising therapeutic strategy in these contexts. Clinical trials of macrophage-based targeted drugs, macrophage-based immunotherapies, and nanoparticle-based therapy were comprehensively summarized. Potential challenges and future directions in targeting macrophages have also been discussed. Overall, our review highlights the significance of this versatile immune cell in human health and disease, which is expected to inform future research and clinical practice.

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

The pancreas, an organ with dual functions, regulates blood glucose levels through the endocrine system by secreting hormones such as insulin and glucagon. It also aids digestion through the exocrine system by secreting digestive enzymes. Complex interactions and signaling mechanisms between the endocrine and exocrine functions of the pancreas play a crucial role in maintaining metabolic homeostasis and overall health. Compelling evidence indicates direct and indirect crosstalk between the endocrine and exocrine parts, influencing the development of diseases affecting both. From a developmental perspective, the exocrine and endocrine parts share the same origin—the “tip-trunk” domain. In certain circumstances, pancreatic exocrine cells may transdifferentiate into endocrine-like cells, such as insulin-secreting cells. Additionally, several pancreatic diseases, including pancreatic cancer, pancreatitis, and diabetes, exhibit potential relevance to both endocrine and exocrine functions. Endocrine cells may communicate with exocrine cells directly through cytokines or indirectly by regulating the immune microenvironment. This crosstalk affects the onset and progression of these diseases. This review summarizes the history and milestones of findings related to the exocrine and endocrine pancreas, their embryonic development, phenotypic transformations, signaling roles in health and disease, the endocrine-exocrine crosstalk from the perspective of diseases, and potential therapeutic targets. Elucidating the regulatory mechanisms of pancreatic endocrine and exocrine signaling and provide novel insights for the understanding and treatment of diseases.

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Responses

Your email address will not be published. Required fields are marked *